Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Mar 2022 for Arena Pharmaceuticals INC.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Nawal Ouzren: trading record in brief
Nawal Ouzren (board member) discloses dealings in Arena Pharmaceuticals Inc to SEC (Form 4). We count 5 filings; the first trade dates from 12 February 2021 and the latest from 11 March 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 11 March 2022, reports a transaction in Arena Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nawal Ouzren
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
890 sharesCommon StockSEC:0001628280-22-005906:0
3,067 shares0Common StockSEC:0001628280-21-012280:0
2 of 2 declarations
